Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,463 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FOLFIRI regimen in advanced colorectal cancer: the experience of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Maiello E, Gebbia V, Giuliani F, Paoletti G, Gebbia N, Borsellino N, Cartenì G, Pezzella G, Manzione L, Romito S, Lopez M, Colucci G; Gruppo Oncologico dell'Italia Meridionale (GOIM). Maiello E, et al. Among authors: lopez m. Ann Oncol. 2005 May;16 Suppl 4:iv56-60. doi: 10.1093/annonc/mdi909. Ann Oncol. 2005. PMID: 15923431 Free article. Clinical Trial.
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: a multicenter randomised phase II study of the Southern Italy Oncology Group.
Maiello E, Gebbia V, Giuliani F, Paoletti G, Gebbia N, Cigolari S, Fortunato S, Pedicini T, Borsellino N, Lopez M, Colucci G. Maiello E, et al. Among authors: lopez m. Ann Oncol. 2000 Aug;11(8):1045-51. doi: 10.1023/a:1008342928408. Ann Oncol. 2000. PMID: 11038044 Free article. Clinical Trial.
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM).
Maiello E, Giuliani F, Gebbia V, Di Renzo N, Pezzella G, Romito S, Mallamaci R, Lopez M, Colucci G; Gruppo Oncologico dell'Italia Meridionale. Maiello E, et al. Among authors: lopez m. Ann Oncol. 2006 Jun;17 Suppl 7:vii55-9. doi: 10.1093/annonc/mdl952. Ann Oncol. 2006. PMID: 16760295 Free article. Clinical Trial.
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
Vici P, Brandi M, Giotta F, Foggi P, Schittulli F, Di Lauro L, Gebbia N, Massidda B, Filippelli G, Giannarelli D, Di Benedetto A, Mottolese M, Colucci G, Lopez M. Vici P, et al. Among authors: lopez m. Ann Oncol. 2012 May;23(5):1121-1129. doi: 10.1093/annonc/mdr412. Epub 2011 Sep 28. Ann Oncol. 2012. PMID: 21965475 Free PMC article. Clinical Trial.
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study.
De Placido S, Lopez M, Carlomagno C, Paoletti G, Palazzo S, Manzione L, Iannace C, Ianniello GP, De Vita F, Ficorella C, Farris A, Pistillucci G, Gemini M, Cortesi E, Adamo V, Gebbia N, Palmeri S, Gallo C, Perrone F, Persico G, Bianco AR. De Placido S, et al. Among authors: lopez m. Br J Cancer. 2005 Oct 17;93(8):896-904. doi: 10.1038/sj.bjc.6602800. Br J Cancer. 2005. PMID: 16222322 Free PMC article. Clinical Trial.
7,463 results